重药控股

000950.SZ

Wind Industry: 医疗保健 > 医疗设备与服务 > 医疗保健提供商与服务 > 保健护理产品经销商

公司服务于医药全产业链的现代医药服务产业集团，同时从事医药流通、医药研发、医疗器械生产并投资参与医药工业。公司为深圳证券交易所上市公司。公司旗下经营主体重庆医药(集团)股份有限公司，前身是成立于1950年的中国医药公司西南区分公司，是中央和地方两级药品医疗器械定点储备单位，也是国内仅有的三家经营麻醉药品和第一类精神药品的全国性批发企业之一，企业规模、市场覆盖居西部领先。公司主营业务医药商业板块涵盖药品、医疗器械、中药饮片、保健产品的医药纯销、商业批发、零售连锁、终端配送、仓储物流及供应链增值服务，公司构建中国医药商业领先的“医药+互联网”平台，开展B2B、B2C、O2O等医药电商业务，通过互联网、物联网、人工智能、大数据应用及移动终端等信息技术支撑，开展慢性病管理、电子处方流转、院外药事管理、远程诊疗等辅助医疗服务。公司拥有国内领先的现代医药物流配送中心，在国内设立多个省级配送中心，并利用院内智能物流技术手段，与大型综合医院开展合作，实现库房前移，与中小型医院及区域医疗中心优势互补，构建中央库房，实现集中配送。公司坚持“献身医药、追求卓越”的企业精神，秉承“责任、人本、和谐、感恩”的核心价值观，立足医药健康产业发展的重大机遇，坚持创新发展，致力于打造国内一流、国际知名的医药健康产业集团。

ESG Score Industry Ranking:
6 / 118 (医疗保健提供商与服务)

ESG Rating Distribution(医疗保健提供商与服务)

AAA

2.54%

17.80%

23.73%

BBB

31.36%

17.80%

1.69%

CCC

Trend of Rating

About Wind ESG Rating

Wind has developed a rigorous rating methodology based on the core connotations of ESG, aligning with international standards and frameworks, and incorporating the characteristics of Chinese companies, to assess the company's essential ESG performance, risk and its ability to operate sustainably.

Focusing on the ESG risks and opportunities of each industry, the companies are rated on a AAA-CCC scale relative to the performance of their industry peers. Wind ESG rating is updated annually or in response to major changes.

The Wind ESG Rating Issuer Communication Platform (esg.wind.com.cn) is now available. Rated companies can access their detailed rating information through this platform, and communicate with or provide feedback to the Wind ESG Rating team regarding specific rating components. For any additional questions, please feel free to send an email to GR.ESG@wind.com.cn.

ESG Score

ESG Score：7.84Updated on 2026-10-29

07.8410

Management & Practices Score：4.85Updated on 2026-10-10

04.857

Controversies Score：2.99Updated on 2026-10-29

02.993

ESG Score Comparison

Indicator	Company Score	Industry Average	Weight
Environmental	5.54	3.34	5.17%
Social	7.03	3.84	67.23%
Governance	6.95	5.25	27.59%

Wind ESG Rating Framework

Building on the foundation of domestic and international ESG policies and standards, our proprietary ESG rating framework considers the development of Chinese capital market and integrates the characteristics of the Chinese companies in various industries. The Wind ESG Rating framework is composed of management & practice and controversies assessment, including:

500+ management & practices indicators, covering E, S and G pillars, reflecting long-term ESG fundamental impacts
1,200+ risk labels, covering news, regulatory penalties and lawsuits, reflecting impact of short-term risks

Management & practice score is the weighted summation of E, S and G pillar scores. The weights reflect both the relative impact of each issue within each industry and the negative or positive contribution of each industry to the environment and society relative to other industries.

Controversies score and ESG score are updated daily, E, S and G pillar scores and management & practice score are updated with underlying data, corresponding data are released on various channels, including Wind Financial Terminal.

Explore More

Wind ESG Rating Methodology.pdf1,198KB Wind ESG Ratings FAQs.pdf755KB

More Details

Peer Comparison(118 companies in the industry) ?

Ranking	Code	Security Name	ESG Rating	ESG Score	Controversies Score	Management & Practices Score	Environmental	Social	Governance
1	300143.SZ	盈康生命	AA	8.89	3.00	5.89	7.09	8.82	7.68
2	2325.HK	云康集团	AA	8.19	2.99	5.19	5.36	7.87	6.73
3	300015.SZ	爱尔眼科	AA	8.17	2.99	5.18	6.28	7.34	7.75
4	9860.HK	艾迪康控股	A	7.97	3.00	4.97	3.99	7.26	7.29
5	000963.SZ	华东医药	A	7.94	3.00	4.94	5.39	7.03	7.45
6	000950.SZ	重药控股	A	7.84	2.99	4.85	5.54	7.03	6.95
7	603882.SH	金域医学	A	7.83	2.94	4.89	4.05	7.26	6.89
8	301103.SZ	何氏眼科	A	7.82	2.98	4.84	4.10	7.35	6.40
9	600056.SH	中国医药	A	7.63	2.99	4.63	4.83	6.45	7.38
10	2666.HK	环球医疗	A	7.61	3.00	4.61	3.78	6.81	6.57